Skip to main content
. 2011 Jan;55(1):39–45. doi: 10.1111/j.1399-6576.2010.02338.x

Fig. 2.

Fig. 2

Serum phosphate levels during the continuous renal replacement therapy treatment. Group 1, receiving Hemosol B0 (diamond), group 2, receiving the phosphate-containing dialysis fluid as the dialysis fluid and Hemosol B0 as the replacement fluid (triangle), and group 3, receiving the phosphate-containing dialysis fluid (square). Groups 2 and 3 were statistically compared with group 1. n=14 patients/group, **P<0.01, ***P<0.001.